(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 26.80%5.03M | 57.60%7.29M | -0.39%4.61M | -30.81%3.81M | -30.81%3.81M | -40.41%3.97M | -36.95%4.62M | -42.64%4.63M | -40.10%5.5M | -40.10%5.5M |
-Cash and cash equivalents | -43.10%2.26M | -48.02%2.4M | -83.11%781.8K | -30.81%3.81M | -30.81%3.81M | -40.41%3.97M | -36.95%4.62M | -42.64%4.63M | -40.10%5.5M | -40.10%5.5M |
-Short term investments | --2.77M | --4.88M | --3.83M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Receivables | -93.70%5.81K | 15.40%12.56K | -99.32%2.55K | -89.80%31.59K | -89.80%31.59K | -20.66%92.29K | -96.14%10.88K | 40.42%375.84K | 109.74%309.8K | 109.74%309.8K |
-Accounts receivable | -93.70%5.81K | 15.40%12.56K | -99.32%2.55K | -89.80%31.59K | -89.80%31.59K | -20.66%92.29K | -96.14%10.88K | 40.42%375.84K | 109.74%309.8K | 109.74%309.8K |
Prepaid assets | -75.88%98.8K | 66.65%140.26K | -58.33%33.37K | -77.97%24.06K | -77.97%24.06K | 6.78%409.58K | 44.07%84.17K | 2.39%80.07K | 222.16%109.23K | 222.16%109.23K |
Total current assets | 14.89%5.13M | 57.67%7.44M | -8.62%4.65M | -34.77%3.86M | -34.77%3.86M | -37.56%4.47M | -38.50%4.72M | -39.58%5.08M | -36.78%5.92M | -36.78%5.92M |
Non current assets | ||||||||||
Net PPE | -69.04%3.45M | -67.37%3.43M | -66.10%3.41M | -64.38%3.39M | -64.38%3.39M | 49.00%11.13M | 52.85%10.51M | 51.48%10.06M | 62.59%9.52M | 62.59%9.52M |
Total non current assets | -69.04%3.45M | -67.37%3.43M | -66.10%3.41M | -64.38%3.39M | -64.38%3.39M | 49.00%11.13M | 52.85%10.51M | 51.48%10.06M | 62.59%9.52M | 62.59%9.52M |
Total assets | -44.99%8.58M | -28.63%10.87M | -46.80%8.06M | -53.02%7.25M | -53.02%7.25M | 6.64%15.6M | 4.67%15.23M | 0.59%15.14M | 1.45%15.44M | 1.45%15.44M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current liabilities | -58.60%225.92K | 26.25%243.86K | -7.35%228.72K | -59.05%215.29K | -59.05%215.29K | 192.64%545.71K | 182.00%193.17K | -31.69%246.87K | -17.21%525.69K | -17.21%525.69K |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | --1 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total liabilities | -58.60%225.92K | 26.25%243.86K | -7.35%228.72K | -59.05%215.29K | -59.05%215.29K | 192.64%545.71K | 182.00%193.17K | -31.69%246.87K | -17.21%525.69K | -17.21%525.69K |
Shareholders'equity | ||||||||||
Share capital | 10.78%19.51M | 10.75%19.51M | 1.15%17.62M | 1.54%17.62M | 1.54%17.62M | 4.86%17.61M | 4.86%17.61M | 4.71%17.42M | 5.07%17.35M | 5.07%17.35M |
-common stock | 10.78%19.51M | 10.75%19.51M | 1.15%17.62M | 1.54%17.62M | 1.54%17.62M | 4.86%17.61M | 4.86%17.61M | 4.71%17.42M | 5.07%17.35M | 5.07%17.35M |
Retained earnings | -200.61%-12.96M | -147.02%-10.68M | -170.24%-11.54M | -194.51%-12.33M | -194.51%-12.33M | -4.98%-4.31M | -6.44%-4.32M | -15.75%-4.27M | -13.76%-4.19M | -13.76%-4.19M |
Other equity interest | 2.89%1.8M | 2.89%1.8M | 0.00%1.75M | 0.00%1.75M | 0.00%1.75M | 0.00%1.75M | 0.00%1.75M | 0.00%1.75M | 0.00%1.75M | 0.00%1.75M |
Total stockholders'equity | -44.50%8.35M | -29.33%10.63M | -47.45%7.83M | -52.81%7.04M | -52.81%7.04M | 4.24%15.05M | 3.83%15.04M | 1.38%14.9M | 2.26%14.91M | 2.26%14.91M |
Total equity | -44.50%8.35M | -29.33%10.63M | -47.45%7.83M | -52.81%7.04M | -52.81%7.04M | 4.24%15.05M | 3.83%15.04M | 1.38%14.9M | 2.26%14.91M | 2.26%14.91M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data